Press release
Global Favipiravir Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028
The global favipiravirmarket is anticipated to grow at a significant CAGR of 4.1% during the forecast period (2022-2028). Favipiravir is a pyrazine carboxamide derivative that acts as an antiviral, which interrupts the viral replication process, preventing the virus from replicating inside the host. The favipiravir market is being driven by the rising prevalence of influenza and Ebola, among other diseases. Furthermore, the usage of this drug in the treatment of COVID-19is also expected to drive market growth.A full report of Global Favipiravir Market is available at:https://orionmarketreports.com/global-favipiravir-market/104999/
The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-
In May 2021, under the brand name 'Favijaj,' Bajaj Healthcare Ltd.(BHL) launched antiviral favipiravir pills. Favipiravir is an antiviral medicine that has been found to be successful in treating COVID-19 patients. It is typically used to treat individuals who are infected with the influenza virus. India's medicines regulator had approved Favijaj to manufacture and sell in the country for the treatment of COVID-19.
In May 2021, Bal Pharma announced the availability of Favipiravir, an antiviral medicine, in the local market under the brand name BALflu for the treatment of COVID-19. Favipiravir slows and terminates viral protein synthesis and promotes deadly influenza virus metagenesis in people with mild to moderate COVID-19 infection. BALflu is a broad-spectrum influenza vaccine that can treat 53 different influenza viruses, including seasonal strains such asebola, arenavirus, bunyavirus, filovirus, WestNile virus, and Lassa virus.
In August 2020, Avigan (Favipiravir) 200 mg tablets launched in India by Dr. Reddy's Laboratories Ltd. The introduction is part of a global license deal with Fujifilm Toyama Chemical Co. Ltd., which gives the Indian pharmaceutical company the rights to produce, market, and distribute the tablets in India. Avigan has been licensed by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID-19 infection.
Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Application
By Distribution Channel
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
· Competitive Landscape-Fujifilm Toyoma Chemicals Co. Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd., and Dr. Reddy's Laboratories Ltd.,among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?
Global Favipiravir Market Report by Segment
By Application
Influenza A&B
Ebola
COVID-19
Others
By Distribution Channel
Hospitals & Clinics
Drug Stores/Pharmacies
Online
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Favipiravir Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast - 2022 to 2028 here
News-ID: 2618350 • Views: …
More Releases from Orion Market Reports
Car Sports Seat Market Provides Information on Historical Growth, Analysis, Oppo …
The Car Sports Seat Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The car sports seat market refers to the industry segment focused on the design, manufacturing, and distribution of specialized seats for sports cars, performance vehicles, and racing applications. These seats are designed to provide enhanced support, comfort, and safety for drivers and passengers during high-performance driving activities.
Car Sports…
Anti-skid Chain Market Growth Drivers, Developments, Technology And Future Trend …
The Anti-skid Chain Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The anti-skid chain market refers to the industry segment focused on the design, manufacturing, and distribution of chains specifically designed to improve traction and prevent skidding in vehicles, particularly in snowy or icy conditions. These chains, also known as snow chains or tire chains, are typically installed on the…
Automotive Disc Brake Module Market Forecast By Industry Outlook 2024-2031
The Automotive Disc Brake Module Market size is expected to grow at an annual average of CAGR 6% during the forecast period (2024-2031). The automotive disc brake module market refers to the industry segment focused on the design, manufacturing, and distribution of complete disc brake systems for vehicles. These modules typically include the disc rotor, brake caliper, brake pads, and associated hardware required for installation.
Automotive Disc Brake Module Market research…
EV Power Inverter Market 2024 Estimation, Consumption, Demand, Industry Trends a …
The EV Power Inverter Market size is expected to grow at an annual average of CAGR 8% during the forecast period (2024-2031). The Electric Vehicle (EV) power inverter market refers to the industry segment focused on the design, production, and distribution of power inverters specifically tailored for electric vehicles. These inverters play a crucial role in converting the DC (direct current) power from the vehicle's battery pack into AC (alternating…
More Releases for Favipiravir
Favipiravir Market to reach USD 247.2 Million - Risk-adjusted numbers with COVID …
The most recent study offered by Acumen Research and Consulting focuses Favipiravir Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Favipiravir Market trends in order to assess its current and future potential. Our Favipiravir Market analysis also provides market participants and new entrants with a comprehensive view of the…
Favipiravir Market Size, Share, Growth, Market Trends, Outlook with Company Anal …
New Jersey, United States,- Favipiravir Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2022 to 2030.
The Global Favipiravir Market research includes an in-depth analysis of key geographical trends, market dynamics, and global size estimates for the market industry. Product description, product classification, industry structure, and numerous participants in…
Favipiravir Market Top Company, Geographical Region, and Industry Segments till …
LOS ANGELES, United States: The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Favipiravir market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Favipiravir market. The authors of the report have segmented the global Favipiravir market as per product, application, and…
Favipiravir Market Global Growth Opportunities and Market Scenario and Forecast …
The global Favipiravir Market" evaluation and insights 2021-2025 is a complete evaluation primarily based totally on in-intensity studies at the improvement environment, marketplace dynamics, opportunities, growth, insights, and rising technology of Favipiravir market. The examiner covers historic information from 2016 to 2021 in addition to predictions 2025, making it a precious useful resource for enterprise executives, rising technology, rising trends, proportion estimation, and nearby overview. By comparing the marketplace's segmentation,…
The Global Favipiravir Market, Growth Analysis, Latest Trends and Forecast till …
Fabipravir, an antiviral medication, has been approved in various countries for the treatment of COVID-19, including Japan, Russia, and India. In September 2020, a fast meta-review (analysing four studies) found that the medicine improved clinical and radiological outcomes; nevertheless, no reduction in mortality or variations in oxygen-support requirements were seen, prompting the search for more robust investigations. In 2020, the global Favipiravir market size was US$ 299.4 million and it…
COVID-19 Update: Favipiravir Drug Market 2020-2028 Investors Seeking Opportuniti …
Favipiravir Drug is an oral anti-viral approved drug for the treatment of influenza. It inhibits and targets the RNA polymerase chain of RNA viruses, such as coronavirus, and stops it from replicating inside the body. It is also effective in rooting out certain strains of mutant influenza viruses, apart from other RNA viruses such as bunyaviruses, filoviruses which can have life-threatening implications.
Favipiravir Drug Market research report yields a comprehensive…
